In parallel with the 2024 JP Morgan Healthcare Conference, PCI hosted its Innovation @ Penn “The Future of Neuroscience” event in San Francisco on January 8, 2024. The event included a panel discussion with Penn experts in the field of brain science and neurotech, including leading Penn luminaries:
- Brian Litt, MD, Perelman School of Medicine Professor of Neurology and Director, Penn Health-Tech
- Michael Kahana, PhD, School of Arts and Sciences Professor of Psychology and Co-Founder & Chairman of the Scientific Advisory Board for Nia Therapeutics
- Anna Wexler, PhD, Perelman School of Medicine Assistant Professor of Medical Ethics and Health Policy
The panel featured in-depth discussions about cutting edge developments in neuroscience innovation at Penn and beyond, including medical devices that interface with the nervous system, neuro-ethics, and the potential impact of AI in neuroscience. The annual PCI-hosted event was well attended by professionals from across the globe in pharma, MedTech and biotech industries and served as a valuable opportunity for attendee networking and connection.
Forbes covered the event as part of a broader review of neurotech-related activities during the conference, highlighting both Anna Wexler and Andrei Georgescu, PhD, co-founder and CEO of Penn spinout Vivodyne. Read the full article here. Watch a video recording of the panel here.